Pharmaceuticalarbitragebalancingaccessandinnovationininternationalprescription中.doc

Draft (Edit Letter No. 1) (7/28/2004) Page 1 of 80 Pharmaceutical Arbitrage: balancing access and innovation in international prescription drug markets Yale J. Health Policy, Law Ethics (Dec. 2004) Kevin Outterson? Introduction Expensive prescription drugs lie at the heart of two major public health issues: the global AIDS epidemic; and US patients obtaining less expensive drugs from Canada over the internet. Both situations call for reducing financial barriers to innovative drugs while maintaining incentives to promote innovation. For better or for worse, the WTO TRIPS Agreement on intellect